Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
12.31
-0.15 (-1.20%)
Nov 7, 2025, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.31 billion as of November 7, 2025. Its market cap has increased by 325.75% in one year.
Market Cap
1.31B
Enterprise Value
969.09M
1-Year Change
325.75%
Ranking
Category
Stock Price
$12.31
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.31B, an increase of 22.81%. That is a compound annual growth rate of 5.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 1.33B | 416.44% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 823.32B |
| Johnson & Johnson | 449.79B |
| AbbVie | 387.30B |
| UnitedHealth Group | 291.27B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.03B |
| Thermo Fisher Scientific | 214.63B |